Gross Profit: Revenues from operations less the associated costs.
Vertex Pharmaceuticals Incorporated (VRTX) had Gross Profit of $2.72B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.19B |
|
$1.19B |
|
$466.00M |
|
|
Gross Profit |
$2.72B |
$1.98B |
|
$1.21B |
|
$125.10M |
|
$1.33B |
|
$1.33B |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
$1.21B |
|
-- |
|
253.90M |
|
256.10M |
|
$4.69 |
|
$4.65 |
|
| Balance Sheet Financials | |
$11.20B |
|
$1.52B |
|
$14.44B |
|
$25.64B |
|
$3.86B |
|
-- |
|
$3.12B |
|
$6.98B |
|
-- |
|
$17.15B |
|
$18.67B |
|
254.00M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|